USPTO Deadlines
Next Deadline
1388 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20231010)
Due Date
October 10, 2029
Grace Period Ends
April 10, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
13 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 2, 2023 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Nov 13, 2023 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Nov 13, 2023 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Nov 9, 2023 | GPAR | P | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | Loading... |
| Oct 10, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jul 25, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 5, 2023 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Jun 22, 2023 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 22, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 22, 2022 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Nov 18, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 17, 2022 | LIMI | I | LIMITATION FROM ORIGINAL APPLICATION ENTERED | Loading... |
| Nov 10, 2022 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of hematological, autoimmune, inflammatory, respiratory, and transplantation-related diseases and disorders; pharmaceutical preparations for use in hematology; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for treating respiratory diseases; antidiabetic preparations; human vaccine preparations; medical preparations, namely, pharmaceutical preparations, biological formulations, biological preparations, antibody formulations and protein formulations for immunoregulation and for treatment of immunologic disorders, autoimmune diseases, inflammatory diseases, arthritis, cancer, tumor, central nervous system disorders and metabolic diseases; anti-inflammatory preparations; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of generalized myasthenia gravis; pharmaceutical products for the treatment of bone diseases; pharmaceutical preparations for tumor treatment; pharmaceutical preparations for the treatment of diseases of the metabolic system; dietary supplements
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005